FOCL (Edap TMS) Long-Term Debt: $17.6 Mil (As of Mar. 2026)


FOCL Edap TMS SA FOCL
53 GF Score
Price $5.08
GF Value $4.52
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Edap TMS Long-Term Debt?

Edap TMS FOCL +1.91% 53 Long-Term Debt is $17.6 Mil as of Mar. 2026. GuruFocus rates FOCL with a GF Score™ of 53/100 and a GF Value™ of $4.52 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Edap TMS's Long-Term Debt for the quarter that ended in Mar. 2026 was $17.6 Mil.

Edap TMS's quarterly Long-Term Debt increased from Sep. 2025 ($1.2 Mil) to Dec. 2025 ($15.9 Mil) and increased from Dec. 2025 ($15.9 Mil) to Mar. 2026 ($17.6 Mil).

Edap TMS's annual Long-Term Debt increased from Dec. 2023 ($2.2 Mil) to Dec. 2024 ($2.2 Mil) and increased from Dec. 2024 ($2.2 Mil) to Dec. 2025 ($15.9 Mil).

Edap TMS  (NAS:FOCL) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Edap TMS Long-Term Debt Related Terms

Edap TMS Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Edap TMS's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edap TMS Long-Term Debt Chart

Edap TMS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.58 3.85 2.21 2.25 15.90

Edap TMS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.75 1.20 1.18 15.90 17.60
FOCL
53GF Score
Edap TMS SA FOCL
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $17.6 Mil mean?
Edap TMS (FOCL) has a Long-Term Debt of $17.6 Mil as of Mar. 2026.
Is Edap TMS's Long-Term Debt too high?
Edap TMS's current Long-Term Debt is $17.6 Mil. Overall, Edap TMS has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Edap TMS's Long-Term Debt compare to ACH and YI?
Edap TMS's Long-Term Debt of $17.6 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Distribution company?
A good Long-Term Debt depends on the Medical Distribution industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Edap TMS's current Long-Term Debt is $17.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edap TMS stock overvalued right now?
Based on GuruFocus' analysis, Edap TMS (FOCL) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.52, compared to a current price of $5.08 — trading 12.3% above its estimated fair value. The current Long-Term Debt is $17.6 Mil. Edap TMS's overall GF Score™ is 53/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Edap TMS (FOCL), the current Long-Term Debt is $17.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Edap TMS (FOCL) Overvalued in 2026?

Based on GuruFocus' analysis, Edap TMS stock appears to be overvalued. The current stock price of $5.08 is trading 12.3% above its estimated GF Value™ of $4.52. GuruFocus considers Edap TMS to be Modestly Overvalued.

Key valuation signals for FOCL:

  • Long-Term Debt: $17.6 Mil
  • GF Value™: $4.52 vs. price of $5.08 (12.3% above fair value)
  • GF Score™: 53/100 with 7 warning signs

No single metric tells the full story. See the FOCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Edap TMS Business Description

Other Exchanges EDA:Germany
Address Parc d\'Activites La Poudrette-Lamartine, 4/6, rue du Dauphine, Vaulx-en-Velin, FRA, 69120
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.
53GF Score

Get the complete analysis for FOCL

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.08
Price
$4.52
GF Value